Adapt Investment Managers’s Pfizer PFE Stock Holding History

Adapt Investment Managers’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2M	Buy	+465,783	New	+$12.2M	0.09%	103

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Adapt Investment Managers's PFE Position: Q2 2026 in Review

Adapt Investment Managers opened a new position in Pfizer (PFE) in Q2 2026: 465,783 shares worth $11.2M. The stake represents 0.09% of the portfolio and ranks #103 among its holdings.

990 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Adapt Investment Managers held 465,783 shares of Pfizer worth $11.2M as of Q2 2026.
Pfizer was a new Adapt Investment Managers position in Q2 2026.
Pfizer made up 0.09% of Adapt Investment Managers's portfolio in Q2 2026, its #103 holding.
990 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Adapt Investment Managers's 13F filing for Q2 2026, filed 27 Jul 2026.